monodansylcadaverine has been researched along with Leukemia, Myelogenous, Chronic, BCR-ABL Positive in 1 studies
monodansylcadaverine: inhibits cross linkage of fibrin
monodansylcadaverine : A sulfonamide obtained by formal condensation of the sulfo group of 5-(dimethylamino)naphthalene-1-sulfonic acid with one of the amino groups of cadaverine.
Leukemia, Myelogenous, Chronic, BCR-ABL Positive: Clonal hematopoetic disorder caused by an acquired genetic defect in PLURIPOTENT STEM CELLS. It starts in MYELOID CELLS of the bone marrow, invades the blood and then other organs. The condition progresses from a stable, more indolent, chronic phase (LEUKEMIA, MYELOID, CHRONIC PHASE) lasting up to 7 years, to an advanced phase composed of an accelerated phase (LEUKEMIA, MYELOID, ACCELERATED PHASE) and BLAST CRISIS.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Guo, S | 1 |
Pridham, KJ | 1 |
Virbasius, CM | 1 |
He, B | 1 |
Zhang, L | 1 |
Varmark, H | 1 |
Green, MR | 1 |
Sheng, Z | 1 |
1 other study available for monodansylcadaverine and Leukemia, Myelogenous, Chronic, BCR-ABL Positive
Article | Year |
---|---|
A large-scale RNA interference screen identifies genes that regulate autophagy at different stages.
Topics: Apoptosis Regulatory Proteins; Autophagy; Cadaverine; Cell Line, Tumor; Drug Resistance, Neoplasm; F | 2018 |